logo-loader
viewAlpha Tau Medical

Alpha Tau Medical launches first US cancer trial

Alpha Tau Medical CFO Raphi Levy spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The Israel-based company is looking to treat solid tumor cancer with its interstitial radioactive seed technology that continually releases short-lived alpha-emitting atoms into the tumor. Recently, the company revealed results from its first clinical trial in patients with squamous cell carcinoma.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Helix Technologies following up strong 2019 with success in 2020

Helix Technologies (OTCQB: HLIX) President of Data Services Garvis Toler joined Steve Darling from Proactive Vancouver to discuss the company releasing their 2019 financial numbers which were very strong and also what milestones they hit to close the year.  Toler also told Proactive...

2 days, 13 hours ago

2 min read